Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 33 entries
Sorted by: Best Match Show Resources per page
A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG

Briars L, Todd T.
PMID: 27453697
J Pediatr Pharmacol Ther. 2016 May-Jun;21(3):192-206. doi: 10.5863/1551-6776-21.3.192.

Attention-deficit/hyperactivity disorder (ADHD) is a common psychological diagnosis in children. This disorder impacts children and adolescents in all areas of life, including academic performance, extracurricular activities, and social interactions. ADHD can continue into adulthood where unemployment and substance abuse...

Cite
Briars L, Todd T. A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. J Pediatr Pharmacol Ther. 2016;21(3):192-206doi: 10.5863/1551-6776-21.3.192.
Briars, L., & Todd, T. (2016). A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 21(3), 192-206. https://doi.org/10.5863/1551-6776-21.3.192
Briars, Leslie, and Todd, Timothy. "A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder." The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG vol. 21,3 (2016): 192-206. doi: https://doi.org/10.5863/1551-6776-21.3.192
Briars L, Todd T. A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. J Pediatr Pharmacol Ther. 2016 May-Jun;21(3):192-206. doi: 10.5863/1551-6776-21.3.192. PMID: 27453697; PMCID: PMC4956327.
Copy Download .nbib Format: NLM
Diagnosis and management of central hypersomnias.

Therapeutic advances in neurological disorders

Sonka K, Susta M.
PMID: 22973425
Ther Adv Neurol Disord. 2012 Sep;5(5):297-305. doi: 10.1177/1756285612454692.

Central hypersomnias are diseases manifested in excessive daytime sleepiness (EDS) not caused by disturbed nocturnal sleep or misaligned circadian rhythms. Central hypersomnias includes narcolepsy with and without cataplexy, recurrent hypersomnia, idiopathic hypersomnia, with and without long sleep time, behaviorally...

Cite
Sonka K, Susta M. Diagnosis and management of central hypersomnias. Ther Adv Neurol Disord. 2012;5(5):297-305doi: 10.1177/1756285612454692.
Sonka, K., & Susta, M. (2012). Diagnosis and management of central hypersomnias. Therapeutic advances in neurological disorders, 5(5), 297-305. https://doi.org/10.1177/1756285612454692
Sonka, Karel, and Susta, Marek. "Diagnosis and management of central hypersomnias." Therapeutic advances in neurological disorders vol. 5,5 (2012): 297-305. doi: https://doi.org/10.1177/1756285612454692
Sonka K, Susta M. Diagnosis and management of central hypersomnias. Ther Adv Neurol Disord. 2012 Sep;5(5):297-305. doi: 10.1177/1756285612454692. PMID: 22973425; PMCID: PMC3437530.
Copy Download .nbib Format: NLM
New frontiers of neuropharmacologic treatment of brain injury agitation.

NeuroRehabilitation

Bell KR, Cardenas DC.
PMID: 24525538
NeuroRehabilitation. 1995;5(3):233-44. doi: 10.3233/NRE-1995-5306.

The treatment of agitation and aggression in the TBI patient continues to be a challenge in both the immediate period following injury and later, in the community setting. While there are few studies of non-traditional pharmacologic compounds in TBI...

Cite
Bell KR, Cardenas DC. New frontiers of neuropharmacologic treatment of brain injury agitation. NeuroRehabilitation. 1995;5(3):233-44doi: 10.3233/NRE-1995-5306.
Bell, K. R., & Cardenas, D. C. (1995). New frontiers of neuropharmacologic treatment of brain injury agitation. NeuroRehabilitation, 5(3), 233-44. https://doi.org/10.3233/NRE-1995-5306
Bell, K R, and Cardenas, D C. "New frontiers of neuropharmacologic treatment of brain injury agitation." NeuroRehabilitation vol. 5,3 (1995): 233-44. doi: https://doi.org/10.3233/NRE-1995-5306
Bell KR, Cardenas DC. New frontiers of neuropharmacologic treatment of brain injury agitation. NeuroRehabilitation. 1995;5(3):233-44. doi: 10.3233/NRE-1995-5306. PMID: 24525538.
Copy Download .nbib Format: NLM
Drug-induced arterial hypertension - a frequently ignored cause of secondary hypertension: a review.

Acta cardiologica

Diaconu CC, Dediu GN, Iancu MA.
PMID: 29291681
Acta Cardiol. 2018 Jan 01;1-7. doi: 10.1080/00015385.2017.1421445. Epub 2018 Jan 01.

The prevalence of hypertension is likely to grow during the future years, mainly due to aging of the population and increasing prevalence of obesity, as an important risk factor for hypertension. One of the main causes of secondary hypertension,...

Cite
Diaconu CC, Dediu GN, Iancu MA. Drug-induced arterial hypertension - a frequently ignored cause of secondary hypertension: a review. Acta Cardiol. 2018;1-7doi: 10.1080/00015385.2017.1421445.
Diaconu, C. C., Dediu, G. N., & Iancu, M. A. (2018). Drug-induced arterial hypertension - a frequently ignored cause of secondary hypertension: a review. Acta cardiologica, 1-7. https://doi.org/10.1080/00015385.2017.1421445
Diaconu, Camelia Cristina, et al. "Drug-induced arterial hypertension - a frequently ignored cause of secondary hypertension: a review." Acta cardiologica vol. (2018): 1-7. doi: https://doi.org/10.1080/00015385.2017.1421445
Diaconu CC, Dediu GN, Iancu MA. Drug-induced arterial hypertension - a frequently ignored cause of secondary hypertension: a review. Acta Cardiol. 2018 Jan 01;1-7. doi: 10.1080/00015385.2017.1421445. Epub 2018 Jan 01. PMID: 29291681.
Copy Download .nbib Format: NLM
Correction to "The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder across Home and School".

Journal of child and adolescent psychopharmacology

[No authors listed]
PMID: 26938370
J Child Adolesc Psychopharmacol. 2016 Mar 03; doi: 10.1089/cap.2015.0053.cxn. Epub 2016 Mar 03.

No abstract available.

Cite
Correction to "The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder across Home and School". J Child Adolesc Psychopharmacol. 2016;doi: 10.1089/cap.2015.0053.cxn.
(2016). Correction to "The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder across Home and School". Journal of child and adolescent psychopharmacology, . https://doi.org/10.1089/cap.2015.0053.cxn
"Correction to "The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder across Home and School"." Journal of child and adolescent psychopharmacology vol. (2016). doi: https://doi.org/10.1089/cap.2015.0053.cxn
Correction to "The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder across Home and School". J Child Adolesc Psychopharmacol. 2016 Mar 03; doi: 10.1089/cap.2015.0053.cxn. Epub 2016 Mar 03. PMID: 26938370.
Copy Download .nbib Format: NLM
Effects of stimulant medication on divergent and convergent thinking tasks related to creativity in adults with attention-deficit hyperactivity disorder.

Psychopharmacology

McBride M, Appling C, Ferguson B, Gonzalez A, Schaeffer A, Zand A, Wang D, Sam A, Hart E, Tosh A, Fontcha I, Parmacek S, Beversdorf D.
PMID: 34477886
Psychopharmacology (Berl). 2021 Dec;238(12):3533-3541. doi: 10.1007/s00213-021-05970-0. Epub 2021 Sep 03.

RATIONALE: Common pharmacological treatments for attention-deficit hyperactivity disorder (ADHD) are central nervous system stimulants acting as norepinephrine-dopamine reuptake inhibitors. The noradrenergic and dopaminergic systems have been shown to impact performance on tasks assessing creativity. Some previous studies suggest higher...

Cite
McBride M, Appling C, Ferguson B, et al. Effects of stimulant medication on divergent and convergent thinking tasks related to creativity in adults with attention-deficit hyperactivity disorder. Psychopharmacology (Berl). 2021;238(12):3533-3541doi: 10.1007/s00213-021-05970-0.
McBride, M., Appling, C., Ferguson, B., Gonzalez, A., Schaeffer, A., Zand, A., Wang, D., Sam, A., Hart, E., Tosh, A., Fontcha, I., Parmacek, S., & Beversdorf, D. (2021). Effects of stimulant medication on divergent and convergent thinking tasks related to creativity in adults with attention-deficit hyperactivity disorder. Psychopharmacology, 238(12), 3533-3541. https://doi.org/10.1007/s00213-021-05970-0
McBride, Molly, et al. "Effects of stimulant medication on divergent and convergent thinking tasks related to creativity in adults with attention-deficit hyperactivity disorder." Psychopharmacology vol. 238,12 (2021): 3533-3541. doi: https://doi.org/10.1007/s00213-021-05970-0
McBride M, Appling C, Ferguson B, Gonzalez A, Schaeffer A, Zand A, Wang D, Sam A, Hart E, Tosh A, Fontcha I, Parmacek S, Beversdorf D. Effects of stimulant medication on divergent and convergent thinking tasks related to creativity in adults with attention-deficit hyperactivity disorder. Psychopharmacology (Berl). 2021 Dec;238(12):3533-3541. doi: 10.1007/s00213-021-05970-0. Epub 2021 Sep 03. PMID: 34477886.
Copy Download .nbib Format: NLM
The effect of stimulants on irritability in autism comorbid with ADHD: a systematic review.

Neuropsychiatric disease and treatment

Ghanizadeh A, Molla M, Olango GJ.
PMID: 31239689
Neuropsychiatr Dis Treat. 2019 Jun 06;15:1547-1555. doi: 10.2147/NDT.S194022. eCollection 2019.

No abstract available.

Cite
Ghanizadeh A, Molla M, Olango GJ. The effect of stimulants on irritability in autism comorbid with ADHD: a systematic review. Neuropsychiatr Dis Treat. 2019;15:1547-1555doi: 10.2147/NDT.S194022.
Ghanizadeh, A., Molla, M., & Olango, G. J. (2019). The effect of stimulants on irritability in autism comorbid with ADHD: a systematic review. Neuropsychiatric disease and treatment, 151547-1555. https://doi.org/10.2147/NDT.S194022
Ghanizadeh, Ahmad, et al. "The effect of stimulants on irritability in autism comorbid with ADHD: a systematic review." Neuropsychiatric disease and treatment vol. 15 (2019): 1547-1555. doi: https://doi.org/10.2147/NDT.S194022
Ghanizadeh A, Molla M, Olango GJ. The effect of stimulants on irritability in autism comorbid with ADHD: a systematic review. Neuropsychiatr Dis Treat. 2019 Jun 06;15:1547-1555. doi: 10.2147/NDT.S194022. eCollection 2019. PMID: 31239689; PMCID: PMC6559223.
Copy Download .nbib Format: NLM
Severe muscle pain and stiffness due to dexmethylphenidate.

Clinical case reports

Kon JJ, Kon AA.
PMID: 32185027
Clin Case Rep. 2020 Jan 25;8(3):420-422. doi: 10.1002/ccr3.2628. eCollection 2020 Mar.

Dexmethylphenidate, and potentially other methylphenidates used in the treatment of attention deficit hyperactivity disorder (ADHD), may cause severe muscle pain and stiffness. Medication side effects should be considered as the possible cause if a patient with ADHD develops severe...

Cite
Kon JJ, Kon AA. Severe muscle pain and stiffness due to dexmethylphenidate. Clin Case Rep. 2020;8(3):420-422doi: 10.1002/ccr3.2628.
Kon, J. J., & Kon, A. A. (2020). Severe muscle pain and stiffness due to dexmethylphenidate. Clinical case reports, 8(3), 420-422. https://doi.org/10.1002/ccr3.2628
Kon, Jacob J, and Kon, Alexander A. "Severe muscle pain and stiffness due to dexmethylphenidate." Clinical case reports vol. 8,3 (2020): 420-422. doi: https://doi.org/10.1002/ccr3.2628
Kon JJ, Kon AA. Severe muscle pain and stiffness due to dexmethylphenidate. Clin Case Rep. 2020 Jan 25;8(3):420-422. doi: 10.1002/ccr3.2628. eCollection 2020 Mar. PMID: 32185027; PMCID: PMC7069845.
Copy Download .nbib Format: NLM
Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries.

Drugs in context

Altin M, El-Shafei AA, Yu M, Desaiah D, Treuer T, Zavadenko N, Gao HY.
PMID: 24432046
Drugs Context. 2013 Sep 13;2013:212260. doi: 10.7573/dic.212260. eCollection 2013 Sep 13.

OBJECTIVE: Functional outcomes were measured over a 12-month period in children and adolescents with attention deficit hyperactivity disorder (ADHD) after they received monotherapy.DESIGN: Prospective, observational, noninterventional study.SETTING: Conducted in six non-Western countries.PARTICIPANTS: Outpatients 6 to 17 years of age...

Cite
Altin M, El-Shafei AA, Yu M, et al. Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries. Drugs Context. 2013;2013:212260doi: 10.7573/dic.212260.
Altin, M., El-Shafei, A. A., Yu, M., Desaiah, D., Treuer, T., Zavadenko, N., & Gao, H. Y. (2013). Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries. Drugs in context, 2013212260. https://doi.org/10.7573/dic.212260
Altin, Murat, et al. "Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries." Drugs in context vol. 2013 (2013): 212260. doi: https://doi.org/10.7573/dic.212260
Altin M, El-Shafei AA, Yu M, Desaiah D, Treuer T, Zavadenko N, Gao HY. Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries. Drugs Context. 2013 Sep 13;2013:212260. doi: 10.7573/dic.212260. eCollection 2013 Sep 13. PMID: 24432046; PMCID: PMC3884848.
Copy Download .nbib Format: NLM
Documenting adherence to psychostimulants in children with ADHD.

Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent

Charach A, Gajaria A, Skyba A, Chen S.
PMID: 18769643
J Can Acad Child Adolesc Psychiatry. 2008 Aug;17(3):131-6.

OBJECTIVE: This study evaluates the validity, inter-rater reliability, and stability over 3 months of a semi-structured telephone interview measuring adherence to stimulant treatment, the Stimulant Adherence Measure, against the Medication Event Monitoring System (MEMS).METHODS: Clinic-referred children (N=22, age 11.85...

Cite
Charach A, Gajaria A, Skyba A, et al. Documenting adherence to psychostimulants in children with ADHD. J Can Acad Child Adolesc Psychiatry. 2008;17(3):131-6
Charach, A., Gajaria, A., Skyba, A., & Chen, S. (2008). Documenting adherence to psychostimulants in children with ADHD. Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent, 17(3), 131-6.
Charach, Alice, et al. "Documenting adherence to psychostimulants in children with ADHD." Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent vol. 17,3 (2008): 131-6.
Charach A, Gajaria A, Skyba A, Chen S. Documenting adherence to psychostimulants in children with ADHD. J Can Acad Child Adolesc Psychiatry. 2008 Aug;17(3):131-6. PMID: 18769643; PMCID: PMC2527765.
Copy Download .nbib Format: NLM
Use of Cognitive Enhancers by Portuguese Medical Students: Do Academic Challenges Matter?.

Acta medica portuguesa

Miranda M, Barbosa M.
PMID: 33507860
Acta Med Port. 2021 Jan 28; doi: 10.20344/amp.14220. Epub 2021 Jan 28.

INTRODUCTION: Nonmedical use of prescription drugs and other substances for cognitive enhancement in the academic environment has been documented in several studies. However, the prevalence among Portuguese university students is unknown. We aimed to assess the prevalence and academic...

Cite
Miranda M, Barbosa M. Use of Cognitive Enhancers by Portuguese Medical Students: Do Academic Challenges Matter?. Acta Med Port. 2021;doi: 10.20344/amp.14220.
Miranda, M., & Barbosa, M. (2021). Use of Cognitive Enhancers by Portuguese Medical Students: Do Academic Challenges Matter?. Acta medica portuguesa, . https://doi.org/10.20344/amp.14220
Miranda, Miguel, and Barbosa, Miguel. "Use of Cognitive Enhancers by Portuguese Medical Students: Do Academic Challenges Matter?." Acta medica portuguesa vol. (2021). doi: https://doi.org/10.20344/amp.14220
Miranda M, Barbosa M. Use of Cognitive Enhancers by Portuguese Medical Students: Do Academic Challenges Matter?. Acta Med Port. 2021 Jan 28; doi: 10.20344/amp.14220. Epub 2021 Jan 28. PMID: 33507860.
Copy Download .nbib Format: NLM
Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release.

Journal of clinical medicine

Weiss M, Childress A, Nordbrock E, Adjei AL, Kupper RJ, Mattingly G.
PMID: 30959790
J Clin Med. 2019 Apr 05;8(4). doi: 10.3390/jcm8040461.

Clinical trials in attention-deficit/hyperactivity disorder (ADHD) have typically measured outcome using clinician ratings on the Attention-Deficit/Hyperactivity Disorder Rating Scale, Fourth Edition (ADHD-RS-IV) and the Clinical Global Impression-Improvement (CGI-I) scale. Remission has been defined as an endpoint score of less...

Cite
Weiss M, Childress A, Nordbrock E, et al. Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release. J Clin Med. 2019;8(4)doi: 10.3390/jcm8040461.
Weiss, M., Childress, A., Nordbrock, E., Adjei, A. L., Kupper, R. J., & Mattingly, G. (2019). Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release. Journal of clinical medicine, 8(4), . https://doi.org/10.3390/jcm8040461
Weiss, Margaret, et al. "Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release." Journal of clinical medicine vol. 8,4 (2019). doi: https://doi.org/10.3390/jcm8040461
Weiss M, Childress A, Nordbrock E, Adjei AL, Kupper RJ, Mattingly G. Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release. J Clin Med. 2019 Apr 05;8(4). doi: 10.3390/jcm8040461. PMID: 30959790; PMCID: PMC6517933.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 33 entries